20n Bio

20n Bio

  • Founded: 2021
  • Location: Malvern, PA
  • Employee range: 1 - 10
  • Funding: $3.3M seed Dec 2021
  • Investors: BlueRun Ventures China



job board

Short description:

Computational Synthetic Biology

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

20n Bio is using computational biology to design novel molecules such as protein therapeutics. At the core of 20n Bio’s philosophy is their open source platform for synthetic biology. Synthetic biology involves using the blueprint of DNA to make molecules biologically and more sustainably. 20n has used their approach to invent organisms that make acetaminophen/paracetamol (APAP) by fermenting sugar. 20n achieved this by engineering an E.coli and a yeast with a gene from a mushroom and over-expression of two native genes. The entire supply of APAP can be generated from petroleum. By using deep learning and biochemistry, 20n offers their Bioreachable Service platform to help teams identify new molecules, or discover more efficient ways to reach a product.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com